Molecular Display of the Animal Meta-Venome for Discovery of Novel Therapeutic Peptides

利用动物宏毒液基因组的分子展示技术发现新型治疗肽

阅读:9
作者:Meng-Hsuan Hsiao ,Yang Miao ,Zixing Liu ,Konstantin Schütze ,Nathachit Limjunyawong ,Daphne Chun-Che Chien ,Wayne Denis Monteiro ,Lee-Shin Chu ,William Morgenlander ,Sahana Jayaraman ,Sung-Eun Jang ,Jeffrey J Gray ,Heng Zhu ,Xinzhong Dong ,Martin Steinegger ,H Benjamin Larman

Abstract

Animal venoms, distinguished by their unique structural features and potent bioactivities, represent a vast and relatively untapped reservoir of therapeutic molecules. However, limitations associated with comprehensively constructing and expressing highly complex venom and venom-like molecule libraries have precluded their therapeutic evaluation via high-throughput screening. Here, we developed an innovative computational approach to design a highly diverse library of animal venoms and "metavenoms". We used programmable M13 hyperphage display to preserve critical disulfide-bonded structures for highly parallelized single-round biopanning with quantitation via high-throughput DNA sequencing. Our approach led to the discovery of Kunitz-type domain containing proteins that target the human itch receptor Mas-related G-protein coupled receptor member X4, which plays a crucial role in itch perception. Deep learning-based structural homology mining identified two endogenous human homologs, tissue factor pathway inhibitor (TFPI), and serine peptidase inhibitor, Kunitz type 2 (SPINT2), which exhibit agonist-dependent potentiation of Mas-related G-protein coupled receptor member X4. Highly multiplexed screening of animal venoms and metavenoms is therefore a promising approach to uncover new drug candidates. Keywords: database mining; itch receptor; ligand discovery; phage display; venom.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。